The Masonic Cancer Center creates a collaborative research environment focused on the causes, prevention, detection, and treatment of cancer; applying that knowledge to improve quality of life for patients and survivors; and sharing its discoveries with other scientists, students, professionals, and the community.
Read the 2016 Annual Report
Chainbreaker is an exciting fundraising experience that includes a weekend of cycling, entertainment, and volunteerism. Find out why taking part is so important to funding research at the Masonic Cancer Center.
The Masonic Cancer Center's clinical partner is University of Minnesota Health. Visit mhealth.org/cancer to find information about cancer care, providers and cancer clinic locations.
Cancer Information Nurse Line
Reach a nurse specializing in cancer care, Monday through Friday from 8 a.m. to 4:30 p.m.
New cancer treatments must prove to be safe and effective in scientific studies with a certain number of patients before they can be made widely available. Through clinical trials, researchers learn which approaches are more effective than others.
Our Research Focus
The Masonic Cancer Center brings together scientists from different disciplines to discover processes that affect cancer. It is home to state-of-the-art research tools and some of the world's top cancer researchers in:
Findings could help determine who’s most at risk for head, neck cancer and inform tobacco patients’ treatment
MINNEAPOLIS/St. PAUL (August 18, 2017) – DNA damage in the mouth caused by carcinogens found in tobacco (known as tobacco-specific nitrosamines) may predict which tobacco users will develop oral/head and neck cancer, according to a new study published in the journal Cancer Prevention Research.
We are pleased to announce the 2017 Minnesota Cancer Centers Partnership Award
Masonic Cancer Center, founded in 1991, is a National Cancer Institute Comprehensive Cancer Center, one of only 47 institutions in the United States and two in Minnesota to hold that designation.
A state-of-the-art facility with 52,000 square feet of laboratory space, which expands the opportunities for collaborative research at the Masonic Cancer Center. It's the gateway to the Biomedical Discovery District.